Revance Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by State Street Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $27M | 2.3M | 11.47 |
| 2023-06-30 | $52M | 2.1M | 25.31 |
| 2023-03-31 | $63M | 1.9M | 32.21 |
| 2022-12-31 | $38M | 2.0M | 18.46 |
| 2022-09-30 | $44M | 1.6M | 27.00 |
| 2022-06-30 | $25M | 1.8M | 13.82 |
| 2022-03-31 | $30M | 1.5M | 19.50 |
| 2021-12-31 | $26M | 1.6M | 16.32 |
| 2021-09-30 | $42M | 1.5M | 27.86 |
| 2021-06-30 | $43M | 1.4M | 29.64 |
| 2021-03-31 | $38M | 1.4M | 27.95 |
| 2020-12-31 | $42M | 1.5M | 28.34 |
| 2020-09-30 | $34M | 1.3M | 25.14 |
| 2020-06-30 | $33M | 1.4M | 24.42 |
| 2020-03-31 | $17M | 1.2M | 14.80 |
| 2019-12-31 | $17M | 1.1M | 16.23 |
| 2019-03-31 | $13M | 813k | 15.76 |
| 2018-12-31 | $14M | 676k | 20.13 |
| 2018-09-30 | $18M | 720k | 24.85 |
| 2018-06-30 | $18M | 669k | 27.45 |
| 2018-03-31 | $18M | 593k | 30.80 |
| 2017-12-31 | $17M | 461k | 35.74 |
| 2017-09-30 | $13M | 466k | 27.55 |
| 2017-06-30 | $12M | 453k | 26.40 |
| 2017-03-31 | $9.4M | 450k | 20.80 |
| 2016-12-31 | $6.7M | 325k | 20.70 |
| 2016-09-30 | $5.0M | 308k | 16.22 |
| 2016-06-30 | $5.8M | 430k | 13.60 |
| 2016-03-31 | $9.2M | 527k | 17.46 |
| 2015-12-31 | $13M | 389k | 34.16 |
| 2015-09-30 | $6.7M | 226k | 29.78 |
| 2015-06-30 | $6.2M | 193k | 32.01 |
| 2015-03-31 | $2.3M | 111k | 20.71 |
| 2014-12-31 | $1.8M | 104k | 16.93 |
| 2014-09-30 | $1.9M | 99k | 19.36 |
| 2014-06-30 | $3.1M | 91k | 34.01 |
| 2014-03-31 | $2.1M | 66k | 31.50 |